Table of Contents
1. Methodology and Scope
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Definitions forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
2 Market Overview
2.1 Direct To Consumer Disease Risk and Health Test Introduction
2.2 Market Analysis by Type
2.2.1 Celiac Disease
2.2.2 Parkinson Disease
2.2.3 Alzheimer Disease
2.2.4 Others
2.3 Market Analysis by Applications
2.3.1 Online
2.3.2 Offline
2.4 Market Analysis by Regions
2.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
2.4.1.1 Germany Market States and Outlook (2013-2026)
2.4.1.2 France Market States and Outlook (2013-2026)
2.4.1.3 UK Market States and Outlook (2013-2026)
2.4.1.4 Italy Market States and Outlook (2013-2026)
2.4.1.5 Russia Market States and Outlook (2013-2026)
2.4.1.6 Turkey Market States and Outlook (2013-2026)
2.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
2.4.2.1 Saudi Arabia Market States and Outlook (2013-2026)
2.4.2.2 UAE Market States and Outlook (2013-2026)
2.4.2.3 Israel Market States and Outlook (2013-2026)
2.4.2.4 Iran Market States and Outlook (2013-2026)
2.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
2.4.3.1 South Africa Market States and Outlook (2013-2026)
2.4.3.2 Nigeria Market States and Outlook (2013-2026)
2.4.3.3 Egypt Market States and Outlook (2013-2026)
2.4.3.4 Algeria Market States and Outlook (2013-2026)
2.5 Market Dynamics
2.5.1 Market Opportunities
2.5.2 Market Risk
2.5.3 Market Driving Force
2.6 Market Competition News and Trend
2.6.1 Merger, Consolidation or Acquisition News
2.6.2 Investment or Disinvestment News
2.6.3 New Product Development and Launch
3 EMEA Direct To Consumer Disease Risk and Health Test Market Competition, by Manufacturer
3.1 EMEA Direct To Consumer Disease Risk and Health Test Sales and Market Share by Manufacturer (2016-2018)
3.1.1 EMEA Direct To Consumer Disease Risk and Health Test Sales by Manufacturer (2016-2018)
3.1.2 EMEA Direct To Consumer Disease Risk and Health Test Sales Market Share by Manufacturer (2016-2018)
3.2 EMEA Direct To Consumer Disease Risk and Health Test Revenue and Market Share by Manufacturer (2016-2018)
3.2.1 EMEA Direct To Consumer Disease Risk and Health Test Revenue by Manufacturer (2016-2018)
3.2.2 EMEA Direct To Consumer Disease Risk and Health Test Revenue Market Share by Manufacturer (2016-2018)
3.3 EMEA Direct To Consumer Disease Risk and Health Test Price by Manufacturer (2016-2018)
3.4 Market Concentration Rate
3.4.1 Top 3 Direct To Consumer Disease Risk and Health Test Manufacturer Market Share (2016-2018)
3.4.2 Top 5 Direct To Consumer Disease Risk and Health Test Manufacturer Market Share (2016-2018)
3.5 Market Competition Trend
4 Manufacturers Profiles
4.1 23andMe
4.1.1 Business Overview
4.1.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.1.2.1 Product A
4.1.2.2 Product B
4.1.3 23andMe Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.2 MyHeritage
4.2.1 Business Overview
4.2.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.2.2.1 Product A
4.2.2.2 Product B
4.2.3 MyHeritage Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.3 LabCorp
4.3.1 Business Overview
4.3.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.3.2.1 Product A
4.3.2.2 Product B
4.3.3 LabCorp Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.4 Myriad Genetics
4.4.1 Business Overview
4.4.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.4.2.1 Product A
4.4.2.2 Product B
4.4.3 Myriad Genetics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.5 Ancestry.com
4.5.1 Business Overview
4.5.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.5.2.1 Product A
4.5.2.2 Product B
4.5.3 Ancestry.com Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.6 Quest Diagnostics
4.6.1 Business Overview
4.6.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.6.2.1 Product A
4.6.2.2 Product B
4.6.3 Quest Diagnostics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.7 Gene By Gene
4.7.1 Business Overview
4.7.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.7.2.1 Product A
4.7.2.2 Product B
4.7.3 Gene By Gene Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.8 DNA Diagnostics Center
4.8.1 Business Overview
4.8.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.8.2.1 Product A
4.8.2.2 Product B
4.8.3 DNA Diagnostics Center Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.9 Invitae
4.9.1 Business Overview
4.9.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.9.2.1 Product A
4.9.2.2 Product B
4.9.3 Invitae Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.10 IntelliGenetics
4.10.1 Business Overview
4.10.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.10.2.1 Product A
4.10.2.2 Product B
4.10.3 IntelliGenetics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.11 Ambry Genetics
4.11.1 Business Overview
4.11.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.11.2.1 Product A
4.11.2.2 Product B
4.11.3 Ambry Genetics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.12 Living DNA
4.12.1 Business Overview
4.12.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.12.2.1 Product A
4.12.2.2 Product B
4.12.3 Living DNA Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.13 EasyDNA
4.13.1 Business Overview
4.13.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.13.2.1 Product A
4.13.2.2 Product B
4.13.3 EasyDNA Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.14 Pathway Genomics
4.14.1 Business Overview
4.14.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.14.2.1 Product A
4.14.2.2 Product B
4.14.3 Pathway Genomics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.15 Centrillion Technology
4.15.1 Business Overview
4.15.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.15.2.1 Product A
4.15.2.2 Product B
4.15.3 Centrillion Technology Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.16 Xcode
4.16.1 Business Overview
4.16.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.16.2.1 Product A
4.16.2.2 Product B
4.16.3 Xcode Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.17 Color Genomics
4.17.1 Business Overview
4.17.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.17.2.1 Product A
4.17.2.2 Product B
4.17.3 Color Genomics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.18 Anglia DNA Services
4.18.1 Business Overview
4.18.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.18.2.1 Product A
4.18.2.2 Product B
4.18.3 Anglia DNA Services Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.19 African Ancestry
4.19.1 Business Overview
4.19.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.19.2.1 Product A
4.19.2.2 Product B
4.19.3 African Ancestry Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.20 Canadian DNA Services
4.20.1 Business Overview
4.20.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.20.2.1 Product A
4.20.2.2 Product B
4.20.3 Canadian DNA Services Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.21 DNA Family Check
4.21.1 Business Overview
4.21.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.21.2.1 Product A
4.21.2.2 Product B
4.21.3 DNA Family Check Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.22 Alpha Biolaboratories
4.22.1 Business Overview
4.22.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.22.2.1 Product A
4.22.2.2 Product B
4.22.3 Alpha Biolaboratories Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.23 Test Me DNA
4.23.1 Business Overview
4.23.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.23.2.1 Product A
4.23.2.2 Product B
4.23.3 Test Me DNA Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.24 23 Mofang
4.24.1 Business Overview
4.24.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.24.2.1 Product A
4.24.2.2 Product B
4.24.3 23 Mofang Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.25 Genetic Health
4.25.1 Business Overview
4.25.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.25.2.1 Product A
4.25.2.2 Product B
4.25.3 Genetic Health Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.26 DNA Services of America
4.26.1 Business Overview
4.26.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.26.2.1 Product A
4.26.2.2 Product B
4.26.3 DNA Services of America Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.27 Shuwen Health Sciences
4.27.1 Business Overview
4.27.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.27.2.1 Product A
4.27.2.2 Product B
4.27.3 Shuwen Health Sciences Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.28 Mapmygenome
4.28.1 Business Overview
4.28.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.28.2.1 Product A
4.28.2.2 Product B
4.28.3 Mapmygenome Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.29 Full Genomes
4.29.1 Business Overview
4.29.2 Direct To Consumer Disease Risk and Health Test Type and Applications
4.29.2.1 Product A
4.29.2.2 Product B
4.29.3 Full Genomes Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
5 EMEA Direct To Consumer Disease Risk and Health Test Market Analysis by Regions
5.1 EMEA Direct To Consumer Disease Risk and Health Test Sales, Revenue and Market Share by Regions
5.1.1 EMEA Direct To Consumer Disease Risk and Health Test Sales by Regions (2013-2018)
5.1.2 EMEA Direct To Consumer Disease Risk and Health Test Revenue by Regions (2013-2018)
5.2 Europe Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
5.3 Middle East Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
5.4 Africa Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6 Europe Direct To Consumer Disease Risk and Health Test by Countries, Type, Application and Manufacturers
6.1 Europe Direct To Consumer Disease Risk and Health Test Sales, Revenue and Market Share by Countries
6.1.1 Europe Direct To Consumer Disease Risk and Health Test Sales by Countries (2013-2018)
6.1.2 Europe Direct To Consumer Disease Risk and Health Test Revenue by Countries (2013-2018)
6.1.3 Germany Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6.1.4 France Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6.1.5 UK Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6.1.6 Russia Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6.1.7 Italy Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6.1.8 Turkey Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6.2 Europe Direct To Consumer Disease Risk and Health Test Sales and Revenue (value) by Manufacturers (2016-2018)
6.2.1 Europe Direct To Consumer Disease Risk and Health Test Sales by Manufacturers (2016-2018)
6.2.2 Europe Direct To Consumer Disease Risk and Health Test Revenue by Manufacturers (2016-2018)
6.3 Europe Direct To Consumer Disease Risk and Health Test Sales and Sales Share by Type (2013-2018)
6.3.1 Europe Direct To Consumer Disease Risk and Health Test Sales by Type (2013-2018)
6.3.2 Europe Direct To Consumer Disease Risk and Health Test Sales Share by Type (2013-2018)
6.4 Europe Direct To Consumer Disease Risk and Health Test Sales and Sales Share by Application (2013-2018)
6.4.1 Europe Direct To Consumer Disease Risk and Health Test Sales by Application (2013-2018)
6.4.2 Europe Direct To Consumer Disease Risk and Health Test Sales Share by Application (2013-2018)
7 Middle East Direct To Consumer Disease Risk and Health Test by Countries, Type, Application and Manufacturers
7.1 Middle East Direct To Consumer Disease Risk and Health Test Sales, Revenue and Market Share by Countries
7.1.1 Middle East Direct To Consumer Disease Risk and Health Test Sales by Countries (2013-2018)
7.1.2 Middle East Direct To Consumer Disease Risk and Health Test Revenue by Countries (2013-2018)
7.1.3 Saudi Arabia Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
7.1.4 Israel Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
7.1.5 UAE Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
7.1.6 Iran Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
7.2 Middle East Direct To Consumer Disease Risk and Health Test Sales and Revenue (value) by Manufacturers (2016-2018)
7.2.1 Middle East Direct To Consumer Disease Risk and Health Test Sales by Manufacturers (2016-2018)
7.2.2 Middle East Direct To Consumer Disease Risk and Health Test Revenue by Manufacturers (2016-2018)
7.3 Middle East Direct To Consumer Disease Risk and Health Test Sales and Sales Share by Type (2013-2018)
7.2.1 Middle East Direct To Consumer Disease Risk and Health Test Sales by Type (2013-2018)
7.2.2 Middle East Direct To Consumer Disease Risk and Health Test Sales Share by Type (2013-2018)
7.4 Middle East Direct To Consumer Disease Risk and Health Test Sales and Sales Share by Application (2013-2018)
7.4.1 Middle East Direct To Consumer Disease Risk and Health Test Sales by Application (2013-2018)
7.4.2 Middle East Direct To Consumer Disease Risk and Health Test Sales Share by Application (2013-2018)
8 Africa Direct To Consumer Disease Risk and Health Test by Countries, Type, Application and Manufacturers
8.1 Africa Direct To Consumer Disease Risk and Health Test Sales, Revenue and Market Share by Countries
8.1.1 Africa Direct To Consumer Disease Risk and Health Test Sales by Countries (2013-2018)
8.1.2 Africa Direct To Consumer Disease Risk and Health Test Revenue by Countries (2013-2018)
8.1.3 South Africa Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
8.1.4 Nigeria Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
8.1.5 Egypt Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
8.1.6 Algeria Direct To Consumer Disease Risk and Health Test Sales and Growth Rate (2013-2018)
8.2 Middle East Direct To Consumer Disease Risk and Health Test Sales and Revenue (value) by Manufacturers (2016-2018)
8.2.1 Middle East Direct To Consumer Disease Risk and Health Test Sales by Manufacturers (2016-2018)
8.2.2 Middle East Direct To Consumer Disease Risk and Health Test Revenue by Manufacturers (2016-2018)
8.3 Middle East Direct To Consumer Disease Risk and Health Test Sales and Sales Share by Type (2013-2018)
8.3.1 Middle East Direct To Consumer Disease Risk and Health Test Sales by Type (2013-2018)
8.3.2 Middle East Direct To Consumer Disease Risk and Health Test Sales Share by Type (2013-2018)
8.4 Middle East Direct To Consumer Disease Risk and Health Test Sales and Sales Share by Application (2013-2018)
8.4.1 Middle East Direct To Consumer Disease Risk and Health Test Sales by Application (2013-2018)
8.4.2 Middle East Direct To Consumer Disease Risk and Health Test Sales Share by Application (2013-2018)
9 EMEA Direct To Consumer Disease Risk and Health Test Market Segment by Type
9.1 EMEA Direct To Consumer Disease Risk and Health Test Sales, Revenue and Market Share by Type (2013-2018)
9.1.1 EMEA Direct To Consumer Disease Risk and Health Test Sales and Market Share by Type (2013-2018)
9.1.2 EMEA Direct To Consumer Disease Risk and Health Test Revenue and Market Share by Type (2013-2018)
9.2 EMEA Celiac Disease Sales Growth Rate and Price
9.2.1 EMEA Celiac Disease Sales Growth Rate (2013-2018)
9.2.2 EMEA Celiac Disease Price (2013-2018)
9.3 Parkinson Disease Sales Growth Rate and Price
9.3.1 EMEA Parkinson Disease Sales Growth Rate (2013-2018)
9.3.2 EMEA Parkinson Disease Price (2013-2018)
9.4 Alzheimer Disease Sales Growth Rate and Price
9.4.1 EMEA Alzheimer Disease Sales Growth Rate (2013-2018)
9.4.2 EMEA Alzheimer Disease Price (2013-2018)
9.5 Others Sales Growth Rate and Price
9.5.1 EMEA Others Sales Growth Rate (2013-2018)
9.5.2 EMEA Others Price (2013-2018)
10 EMEA Direct To Consumer Disease Risk and Health Test Market Segment by Application
10.1 EMEA Direct To Consumer Disease Risk and Health Test Sales Market Share by Application (2013-2018)
10.2 Online Sales Growth Rate (2013-2018)
10.3 Offline Sales Growth Rate (2013-2018)
11 EMEA Direct To Consumer Disease Risk and Health Test Market Forecast (2019-2026)
11.1 EMEA Direct To Consumer Disease Risk and Health Test Sales, Revenue and Growth Rate (2019-2026)
11.2 Direct To Consumer Disease Risk and Health Test Market Forecast by Regions (2019-2026)
11.2.1 Europe Direct To Consumer Disease Risk and Health Test Market Forecast by Regions (2019-2026)
11.2.1.1 Germany Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.1.2 France Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.1.3 UK Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.1.4 Russia Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.1.5 Italy Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.1.6 Turkey Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.2 Middle East Market Forecast by Regions (2019-2026)
11.2.2.1 Saudi Arabia Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.2.2 Israel Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.2.3 UAE Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.2.4 Iran Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.3 Africa Market Forecast by Regions (2019-2026)
11.2.3.1 South Africa Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.3.2 Nigeria Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.3.3 Egypt Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.2.3.4 Algeria Direct To Consumer Disease Risk and Health Test Sales Forecast 2019-2026
11.3 Direct To Consumer Disease Risk and Health Test Market Forecast by Type (2019-2026)
11.3.1 EMEA Direct To Consumer Disease Risk and Health Test Sales Forecast by Type (2019-2026)
11.3.2 EMEA Direct To Consumer Disease Risk and Health Test Market Share Forecast by Type (2019-2026)
11.4 Direct To Consumer Disease Risk and Health Test Market Forecast by Application (2019-2026)
11.4.1 EMEA Direct To Consumer Disease Risk and Health Test Sales Forecast by Application (2019-2026)
11.4.2 EMEA Direct To Consumer Disease Risk and Health Test Market Share Forecast by Application (2019-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Future Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors, Traders and Dealers
12 Research Findings and Conclusion